SCHEMBL7337752

SCHEMBL7337752

CCOC(=O)CC(NC(=O)CNC(=O)c1cccc(NC(=N)N)c1)c1ccco1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
POLB P06746 3/20 0.42
MAPT P10636 2/20 0.42
PKM P14618 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTT P42858 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 2/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 1/20 0.38
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ITGB3 P05106 1/20 0.38
ITGB1 P05556 1/20 0.38
ITGAV P06756 1/20 0.38
ITGA5 P08648 1/20 0.38
ITGB5 P18084 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6777994 0.87 ITGB3 (0.45) NPC1RAB9APOLBMAPTPKM
SCHEMBL3839471 0.87 GPR139 (0.47) MEN1KMT2AITGB3ITGB1ITGAV
SCHEMBL7838133 0.86 F2 (0.38) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL7341726 0.86 GPR139 (0.42) LMNAMEN1KMT2ATSHRALDH1A1
SCHEMBL7837699 0.86 RAB9A (0.50) NPC1RAB9AMAPTPKMKDM4E
SCHEMBL7340341 0.84 F7 (0.41) POLBLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL7340506 0.84 ITGB3 (0.49) NPC1RAB9APOLBMAPTPKM
SCHEMBL7344055 0.84 F7 (0.46) MAPTL3MBTL1SMN1; SMN2ALDH1A1F2
SCHEMBL7341087 0.84 GPR139 (0.48) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL7338356 0.84 SMN1; SMN2 (0.44) NPC1L3MBTL1HTTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP claimed
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP disclosed
US-6028223-A AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0850221-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1998-07-01 EP disclosed
WO-1997008145-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-03-06 WO disclosed